Relmada Therapeutics, Inc. (RLMD): 8-K filed Mar 20, 2026

Form type

8-K

Filing date

Mar 20, 2026

Accession number

0001213900-26-032403

Filer

Relmada Therapeutics, Inc. (CIK 1553643)